These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12710952)

  • 1. Activity of Novispirin G-10, a novel antimicrobial peptide against Chlamydia trachomatis and vaginosis-associated bacteria.
    Yasin B; Pang M; Lehrer RI; Wagar EA
    Exp Mol Pathol; 2003 Apr; 74(2):190-5. PubMed ID: 12710952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cumulative experience examining the effect of natural and synthetic antimicrobial peptides vs. Chlamydia trachomatis.
    Yasin B; Pang M; Wagar EA
    J Pept Res; 2004 Aug; 64(2):65-71. PubMed ID: 15251032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of a cellulose acetate phthalate topical cream against organisms associated with bacterial vaginosis.
    Neurath AR; Li YY; Mandeville R; Richard L
    J Antimicrob Chemother; 2000 May; 45(5):713-4. PubMed ID: 10797102
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of antiseptics on Chlamydia trachomatis growth.
    Párducz L; Eszik I; Wagner G; Burián K; Endrész V; Virok DP
    Lett Appl Microbiol; 2016 Oct; 63(4):260-7. PubMed ID: 27472980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the vaginal microbiota following antibiotic treatment for Mycoplasma genitalium, Chlamydia trachomatis and bacterial vaginosis.
    Ahrens P; Andersen LO; Lilje B; Johannesen TB; Dahl EG; Baig S; Jensen JS; Falk L
    PLoS One; 2020; 15(7):e0236036. PubMed ID: 32722712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examination of Chlamydia trachomatis infection in environments mimicking normal and abnormal vaginal pH.
    Yasin B; Pang M; Wagar EA; Lehrer RI
    Sex Transm Dis; 2002 Sep; 29(9):514-9. PubMed ID: 12218842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonoptimal Vaginal Microbiota After Azithromycin Treatment for Chlamydia trachomatis Infection.
    Tamarelle J; Ma B; Gajer P; Humphrys MS; Terplan M; Mark KS; Thiébaut ACM; Forney LJ; Brotman RM; Delarocque-Astagneau E; Bavoil PM; Ravel J
    J Infect Dis; 2020 Feb; 221(4):627-635. PubMed ID: 31573603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole compared to metronidazole, tinidazole and clindamycin.
    Petrina MAB; Cosentino LA; Rabe LK; Hillier SL
    Anaerobe; 2017 Oct; 47():115-119. PubMed ID: 28522362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-HIV microbicide candidate RC-101 inhibits pathogenic vaginal bacteria without harming endogenous flora or mucosa.
    Eade CR; Cole AL; Diaz C; Rohan LC; Parniak MA; Marx P; Tarwater PM; Gupta P; Cole AM
    Am J Reprod Immunol; 2013 Feb; 69(2):150-8. PubMed ID: 23167830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns.
    Steinstraesser L; Tack BF; Waring AJ; Hong T; Boo LM; Fan MH; Remick DI; Su GL; Lehrer RI; Wang SC
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1837-44. PubMed ID: 12019098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of Mobiluncus species from the human vagina.
    Gatti M
    Zentralbl Bakteriol; 2000 Jan; 289(8):869-78. PubMed ID: 10705619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro inhibitory activity of human vaginal lactobacilli against pathogenic bacteria associated with bacterial vaginosis in Kenyan women.
    Matu MN; Orinda GO; Njagi EN; Cohen CR; Bukusi EA
    Anaerobe; 2010 Jun; 16(3):210-5. PubMed ID: 19925874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole.
    Austin MN; Beigi RH; Meyn LA; Hillier SL
    J Clin Microbiol; 2005 Sep; 43(9):4492-7. PubMed ID: 16145097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cationic amphiphiles against Gardnerella vaginalis resistant strains and bacterial vaginosis-associated pathogens.
    Weeks RM; Moretti A; Song S; Uhrich KE; Karlyshev AV; Chikindas ML
    Pathog Dis; 2019 Nov; 77(8):. PubMed ID: 31603505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Cetyltrimethylammonium naproxenate on the adherence of Gardnerella vaginalis, Mobiluncus curtisii, and Lactobacillus acidophilus to vaginal epithelial cells.
    Catalanotti P; Rossano F; de Paolis P; Baroni A; Buttini G; Tufano MA
    Sex Transm Dis; 1994; 21(6):338-44. PubMed ID: 7871448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of a sensitive system for analysis of human vaginal microbiota on the basis of rRNA-targeted reverse transcription-quantitative PCR.
    Kurakawa T; Ogata K; Tsuji H; Kado Y; Takahashi T; Kida Y; Ito M; Okada N; Nomoto K
    J Microbiol Methods; 2015 Apr; 111():93-104. PubMed ID: 25661498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of Compounds against Gardnerella vaginalis Biofilms.
    Gottschick C; Szafranski SP; Kunze B; Sztajer H; Masur C; Abels C; Wagner-Döbler I
    PLoS One; 2016; 11(4):e0154086. PubMed ID: 27111438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Biofilm Formation by Gardnerella vaginalis and Other Anaerobes on Bacterial Vaginosis.
    Machado A; Cerca N
    J Infect Dis; 2015 Dec; 212(12):1856-61. PubMed ID: 26080369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health gains from screening for infection of the lower genital tract in women attending for termination of pregnancy.
    Blackwell AL; Thomas PD; Wareham K; Emery SJ
    Lancet; 1993 Jul; 342(8865):206-10. PubMed ID: 8100930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of Chlamydia trachomatis to protegrins and defensins.
    Yasin B; Harwig SS; Lehrer RI; Wagar EA
    Infect Immun; 1996 Mar; 64(3):709-13. PubMed ID: 8641770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.